Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $4.24 billion
P/E Ratio 322.73
Dividend Yield 0.38%
Shares Outstanding 1.63 billion
Earnings per share -0.004
Dividend per share 0.01
Year To Date Return 159.70%
Earnings Yield 0.31%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare Ltd (ASX: SIG)
    Latest News

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why ASX, Baby Bunting, Bowen Coking Coal, and EBOS shares are sinking today

    These ASX shares are falling heavily on Tuesday.

    Read more »

    A man sees some good news on his phone and gives a little cheer.
    Share Gainers

    Why A2 Milk, Perenti, Sigma Healthcare, and Synlait shares are racing higher

    These ASX shares are having a strong session on Tuesday.

    Read more »

    A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
    Healthcare Shares

    Sigma Healthcare share price surges 30% on $3bn Chemist Warehouse deal

    A major contract win is putting a rocket under this share today.

    Read more »

    A woman peers through a bunch of recycled clothes on hangers and looks amazed.
    Value Investing

    Don't get duped: Why cheap ASX shares can still rip you off

    This might be the most important lesson I have learnt as an investor.

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Earnings Results

    Sigma Healthcare share price falls despite company's return to profit

    The pharmaceutical company announced an FY23 profit of $1.8 million, up from a $7.2 million loss in FY22. 

    Read more »

    Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
    Share Gainers

    3 'boring' ASX shares with returns over 25% in 2022

    These stocks might appear dull to some, but they've packed a punch this year.

    Read more »

    Red arrow going down and symbolising a falling share price.
    Share Fallers

    Why 88 Energy, Gold Road, Sigma, and Star shares are dropping

    These ASX shares are having bad days...

    Read more »

    a man in business attire plunges into a room filled with water with bubbles streaming along his body as though he has completed a high dive.
    Healthcare Shares

    Why has the Sigma (ASX:SIG) share price dived 14% so far in December?

    What's happened to Sigma shares?

    Read more »

    A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
    Healthcare Shares

    Sigma (ASX:SIG) share price slides 7% to yearly low on guidance update

    An earnings downgrade has sent the company's share price deeply into the red today.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    01 Oct 2024 $0.0050 0.00% Interim 17 Oct 2024
    28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
    25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
    30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
    29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
    04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
    24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
    06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
    19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
    03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
    12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
    05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
    19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
    06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
    20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
    06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
    03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
    21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
    05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
    16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
    31 Mar 2009 $0.0400 100.00% Final 07 May 2009
    30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
    29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
    02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare Ltd

    Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.

    SIG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Dec 2024 $2.60 $-0.03 -1.14% 9,656,715 $2.62 $2.67 $2.60
    19 Dec 2024 $2.63 $-0.08 -2.95% 6,293,378 $2.64 $2.73 $2.61
    18 Dec 2024 $2.71 $-0.01 -0.37% 6,266,111 $2.70 $2.78 $2.68
    17 Dec 2024 $2.72 $0.05 1.87% 9,565,765 $2.73 $2.77 $2.64
    16 Dec 2024 $2.67 $-0.12 -4.30% 14,795,564 $2.74 $2.75 $2.57
    13 Dec 2024 $2.79 $0.05 1.82% 4,596,290 $2.75 $2.82 $2.72
    12 Dec 2024 $2.74 $-0.08 -2.84% 7,371,405 $2.83 $2.84 $2.66
    11 Dec 2024 $2.82 $0.00 0.00% 6,060,467 $2.80 $2.87 $2.80
    10 Dec 2024 $2.82 $-0.06 -2.08% 4,861,474 $2.86 $2.88 $2.79
    09 Dec 2024 $2.88 $0.00 0.00% 5,288,299 $2.90 $2.93 $2.82
    06 Dec 2024 $2.88 $0.01 0.35% 5,722,506 $2.87 $2.90 $2.86
    05 Dec 2024 $2.87 $-0.03 -1.03% 7,755,739 $2.89 $2.93 $2.84
    04 Dec 2024 $2.90 $-0.01 -0.34% 5,592,131 $2.91 $2.92 $2.85
    03 Dec 2024 $2.91 $0.05 1.75% 8,515,254 $2.87 $2.96 $2.85
    02 Dec 2024 $2.86 $-0.03 -1.04% 9,449,624 $2.95 $3.01 $2.82
    29 Nov 2024 $2.89 $0.11 3.96% 7,733,551 $2.82 $2.92 $2.76
    28 Nov 2024 $2.78 $0.08 2.96% 13,447,827 $2.74 $2.93 $2.74
    27 Nov 2024 $2.70 $0.02 0.75% 6,488,510 $2.68 $2.73 $2.61
    26 Nov 2024 $2.68 $0.05 1.90% 8,768,105 $2.67 $2.73 $2.60
    25 Nov 2024 $2.63 $0.08 3.14% 13,131,100 $2.58 $2.64 $2.57
    22 Nov 2024 $2.55 $0.13 5.37% 8,855,595 $2.44 $2.60 $2.44

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    10 Jul 2024 Michael Sammells Buy 7,866 $10,054
    Directors' share plan.
    10 Jul 2024 Kathryn (Kate) Spargo Buy 4,747 $6,067
    Directors' share plan.
    10 Jul 2024 Christopher Roberts Buy 3,661 $4,680
    Directors' share plan.
    10 Jul 2024 Neville Mitchell Buy 4,340 $5,548
    Directors' share plan.
    10 Jul 2024 Annette Carey Buy 3,662 $4,681
    Directors' share plan.
    08 Apr 2024 Michael Sammells Buy 7,855 $9,582
    Directors' share plan.
    08 Apr 2024 Neville Mitchell Buy 4,334 $5,286
    Directors' share plan.
    08 Apr 2024 Christopher Roberts Buy 3,657 $4,461
    Directors' share plan.
    08 Apr 2024 Annette Carey Buy 3,656 $4,459
    Directors' share plan.
    08 Apr 2024 Kathryn (Kate) Spargo Buy 4,740 $5,782
    Directors' share plan.
    29 Jan 2024 Kathryn (Kate) Spargo Issued 111,548 $78,083
    Rights issue.
    29 Jan 2024 Kathryn (Kate) Spargo Issued 129,730 $90,811
    Rights issue.
    29 Jan 2024 Michael Sammells Issued 81,444 $57,010
    Rights issue.
    29 Jan 2024 Annette Carey Issued 3,708 $2,595
    Rights issue.
    29 Jan 2024 Neville Mitchell Issued 6,474 $4,531
    Rights issue.
    10 Jan 2024 Kathryn (Kate) Spargo Buy 5,442 $5,169
    Directors' share plan.
    10 Jan 2024 Christopher Roberts Buy 4,696 $4,460
    Directors' share plan.
    10 Jan 2024 Michael Sammells Buy 10,612 $10,079
    Directors' share plan.
    10 Jan 2024 Annette Carey Buy 4,697 $4,461
    Directors' share plan.
    10 Jan 2024 Neville Mitchell Buy 5,566 $5,286
    Directors' share plan.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts has more than 40 years' experience in the medical device industry, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a Director until November 2017. He Held Directorship in Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell has financial experience coupled with experience as an active Non-Executive Director. Mr Mitchell is a current Director and Chair of the Audit Committee of Sonic Healthcare. Mr Mitchell is also a Non-Executive Director and Chair of the Audit and Risk Committee of Fisher and Paykel Healthcare. Previously, Mr Mitchell has held other Director roles including South Eastern Sydney Local Health District, The Board of Taxation, Sirtex Medical and Osprey Medical Inc. Mr Mitchell is a qualified Chartered Accountant with international healthcare and finance experience. Prior to becoming a Non-Executive Director, Mr Mitchell had a career spanning 27 years with Cochlear Limited, 22 of those years as Chief Financial Officer and Company Secretary.
    Ms Kathryn (Kate) Dianne Spargo Non-Executive Director Dec 2015
    Ms Spargo has gained business experience as an advisor, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently a Non-Executive Director at the following listed entities is Sonic Healthcare Limited, Adairs Limited and Bapcor Ltd. In addition Ms Spargo is also currently a Non-Executive Director at CIMIC Ltd (now unlisted). Over the last three years, Ms Spargo was a Non-Executive Director at Xenith IP Ltd. In September 2021, Ms Spargo retired from her position as Chairman of CoInvest and at the same time joined the board of the unlisted company Jellis Craig. Ms Spargo is also Director at the Geelong Football Club and Future Fuels Cooperative Research Centre.
    Mr Michael Sammells Non-Executive DirectorInterim Chairman Feb 2020
    Mr Sammells has 35 years of broad experience in finance, corporate services and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a current Director of GMHBA Limited and is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder has culmination of a 28 year career with the Clicks Group which included 18 years as part of the executive team. Before becoming Clicks CEO Vikesh held a number of roles within the Group, including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesaler business, United Pharmaceutical Distributors.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is a current Director of National Intermodal Corporation, a Non-Executive Director of Flinders Port Holdings Pty Ltd, a Non-Executive Director of Kinetic, and an Advisory Board Member of Orizontas. Prior to that, Ms Carey has been a Director of Linfox Armaguard Pty Ltd and Sai Cheng Logistics Inc and was Chair of Australia Post Global. Ms Carey brings a balance of technical expertise as well as legal, strategic, and commercial intellect from over 20 years' experience in supply chain, logistics and cross border ecommerce. Ms Carey has previously held various senior roles within the Linfox Logistics group progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post. Ms Carey is a member of Chief Executive Women.
    Ms Kara McGowan General CounselCompany Secretary Oct 2021
    -
    Kara McGowan General CounselCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hmc Capital Partners Holdings Pty Ltd 311,242,135 19.07%
    Hsbc Custody Nominees (Australia) Limited 295,751,528 18.12%
    Citicorp Nominees Pty Limited 248,058,343 15.20%
    J P Morgan Nominees Australia Pty Limited 164,445,049 10.08%
    National Nominees Limited 64,967,710 3.98%
    Sigma Employee Share Admin P/L 37,184,497 2.28%
    Pacific Custodians Pty Limited 32,103,793 1.97%
    Ubs Nominees Pty Ltd 27,854,014 1.71%
    Bnp Paribas Nominees Pty Ltd 12,983,279 0.80%
    Hsbc Custody Nominees (Australia) Limited II 11,673,531 0.72%
    Bnp Paribas Noms Pty Ltd 11,172,115 0.68%
    Invia Custodian Pty Limited 7,596,481 0.47%
    Hsbc Custody Nominees (Australia) Limited A/C 2 7,365,783 0.45%
    Warbont Nominees Pty Ltd 5,805,877 0.36%
    Lygon Finance Pty Ltd 4,906,459 0.30%
    Citicorp Nominees Pty Limited II 4,794,059 0.29%
    Merrill Lynch (Australia) Nominees Pty Limited 4,281,681 0.26%
    Bnpp Noms Pty Ltd Hub24 Custodial Serv Ltd 4,049,515 0.25%
    Bnp Paribas Nominees Pty Ltd Barclays 3,406,856 0.21%
    Netwealth Investments Limited 3,315,488 0.20%

    Profile

    since

    Note